4//SEC Filing
Shabahang Shahrokh 4
Accession 0001213900-20-035129
CIK 0001726711other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 9:20 PM ET
Size
5.4 KB
Accession
0001213900-20-035129
Insider Transaction Report
Form 4
Shabahang Shahrokh
DirectorCHIEF INNOVATION OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2020-11-02+110,000→ 110,000 totalExercise: $1.92Exp: 2030-11-02→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]The options shall vest as to 50% of the total shares on November 2, 2021, after which the remaining 50% of the total shares shall vest in four successive equal quarterly installments.
Documents
Issuer
ADiTx Therapeutics, Inc.
CIK 0001726711
Entity typeother
Related Parties
1- filerCIK 0001816754
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 9:20 PM ET
- Size
- 5.4 KB